ALMR
Alamar Biosciences, Inc.
$25.30
+0.07 (+0.28%)
At close · Jul 8
Market Cap
$1.84B
Shares
69,311,186
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$25.30
Open$24.90
Day$24.26–25.52
52W$18.90–28.68
Avg vol 30d318K
Short int1.9M · 2.7% float · 11.5d
Short vol86%
DataApr 2026–Jul 2026
Filing10-Q · May 8
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Limited
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+10%
above
RSI (14)
58
neutral
MACD trend
Positive
52-week position
65%
mid-range
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Accumulating
Net +$8.0M over 90 days · 0% sells
Short interest
Rising
2.71% of float · ▲ +6.0% MoM · 11.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
82
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
70%
annualized · 1-yr
Max drawdown
−28%
past year
ATR
6.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 8, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+10%
Bullish
RSI (14)
58
Neutral
MACD trend
Positive
Bullish
52-week position
65%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Accumulating
Net +$8.0M over 90 days · 0% sells
Short interest
Rising
2.71% of float · ▲ +6.0% MoM · 11.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $19
Now $25 · 65%
52-wk high $29
vs 50-day avg +10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALMR
this stock
Alamar Biosciences, Inc.
|
$1.84B | — | — | — | 2.7% |
|
ABT
Abbott Laboratories
|
$164.43B | -23.6% | +5.7% | 26.4 | 1.3% |
|
SYK
Stryker Corp
|
$125.40B | -6.8% | +11.2% | 37.9 | 1.6% |
|
MDT
Medtronic plc
|
$105.46B | -13.9% | +8.4% | 22.1 | 1.4% |
|
BSX
Boston Scientific Corp
|
$66.87B | -53.0% | +5.5% | 18.8 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALMR | -6.6% | +31.7% | — | -6.6% | — |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -6.4% | +30.9% | — | -6.4% | — |